We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

34 hedge funds and large institutions have $18.9M invested in OncoSec Medical Incorporated in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

11% less funds holding

Funds holding: 38 → 34 (-4)

26% less capital invested

Capital invested by funds: $25.6M → $18.9M (-$6.74M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NC
Nexthera Capital
New York
+$876K
2
6CM
683 Capital Management
New York
+$478K
3
BlackRock
BlackRock
New York
+$354K
4
Millennium Management
Millennium Management
New York
+$310K
5
DS
DRW Securities
Illinois
+$175K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.59M
2
UOC
UBS O'Connor
Illinois
-$507K
3
CM
Crestline Management
Texas
-$379K
4
SI
Sofinnova Investments
California
-$126K
5
JP Morgan Chase
JP Morgan Chase
New York
-$94K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
1
Avoro Capital Advisors
New York
$5.53M – – –
NC
2
Nexthera Capital
New York
$3.61M +$876K +2,500 +27%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$3.06M -$1.59M -4,546 -31%
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.69M +$54K +154 +2%
Millennium Management
5
Millennium Management
New York
$1.65M +$310K +885 +19%
6CM
6
683 Capital Management
New York
$414K +$478K +1,364 New
BlackRock
7
BlackRock
New York
$330K +$354K +1,009 +1,310%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$279K +$100K +286 +45%
DS
9
DRW Securities
Illinois
$248K +$175K +500 +157%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$212K +$90.1K +257 +58%
Deutsche Bank
11
Deutsche Bank
Germany
$139K +$161K +458 New
Commonwealth Equity Services
12
Commonwealth Equity Services
Massachusetts
$125K +$22.8K +65 +19%
Northern Trust
13
Northern Trust
Illinois
$119K – – –
Zurich Cantonal Bank
14
Zurich Cantonal Bank
Switzerland
$95K – – –
PA
15
Perceptive Advisors
New York
$69K – – –
DADC
16
D.A. Davidson & Co
Montana
$62K +$2.45K +7 +4%
FAAS
17
First Allied Advisory Services
California
$48K -$1.05K -3 -2%
Goldman Sachs
18
Goldman Sachs
New York
$43K +$49.8K +142 New
Wells Fargo
19
Wells Fargo
California
$34K -$1.4K -4 -3%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$24K – – –
MSAM
21
Moloney Securities Asset Management
Missouri
$21K +$23.8K +68 New
State Street
22
State Street
Massachusetts
$18K – – –
UBS Group
23
UBS Group
Switzerland
$16K +$15.4K +44 +629%
Northwestern Mutual Wealth Management
24
Northwestern Mutual Wealth Management
Wisconsin
$15K – – –
Citadel Advisors
25
Citadel Advisors
Florida
$15K +$17.2K +49 New
1
2

ONCS Hedge Fund Activity: Q2 2018 in Review

34 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2018, worth a combined $18.9M — down 26% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ONCS and 7 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Nexthera Capital, adding an estimated $876K. The largest seller was Point72 Asset Management, cutting an estimated $1.59M.

  • 34 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2018, down from 38 in Q1 2018.
  • Funds reported $18.9M of OncoSec Medical Incorporated stock for Q2 2018, down 26% quarter-over-quarter.
  • 7 funds opened new OncoSec Medical Incorporated positions in Q2 2018 and 10 closed out, a net change of -3 holders.
  • The largest OncoSec Medical Incorporated buyer in Q2 2018 was Nexthera Capital, an estimated $876K added.
  • The largest OncoSec Medical Incorporated seller in Q2 2018 was Point72 Asset Management, an estimated $1.59M sold.

Based on aggregated 13F filings for Q2 2018.